Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Johnson

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Circulation|May 9, 2007
Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Ronald S Freudenberger, Anne S Hellkamp, Jonathan L Halperin, et al.
Environmental and Molecular Mutagenesis|November 14, 2021
Utility of a next-generation framework for assessment of genomic damage: A case study using the pharmaceutical drug candidate etoposideJohn Nicolette, Mirjam Luijten, Jennifer C Sasaki, et al.
Eclinicalmedicine|February 4, 2025
Inter-pregnancy interval and uterine rupture during a trial of labour after one previous caesarean delivery and no previous vaginal births: a retrospective population-based cohort studyPejman Adily, Travis Bettison, Mark Lauer, et al.
AIDS Research and Human Retroviruses|April 18, 2002
Mother-to-child transmission in the United States of subtypes D and A/G human immunodeficiency virus type 1Paul Krogstad, Susan H Eshleman, Yongzhi Geng, et al.
Journal of the American College of Cardiology|April 15, 2014
Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)Daniel P Fishbein, Anne S Hellkamp, Daniel B Mark, et al.
Mutagenesis|October 24, 2024
Industrial Genotoxicology Group: 36th Annual Meeting ReportDarren Kidd, Ian Crooks, Angela Saccardo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2002
Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1Paul Krogstad, Sophia Lee, George Johnson, et al.
Regulatory Toxicology and Pharmacology : RTP|April 16, 2021
Use of less-than-lifetime (LTL) durational limits for nitrosamines: Case study of N-Nitrosodiethylamine (NDEA)Joel P Bercu, Melisa Masuda-Herrera, George Johnson, et al.
Heart Rhythm|June 23, 2015
SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac deathWan-Tai M Au-Yeung, Per G Reinhall, Jeanne E Poole, et al.
Journal of the American College of Cardiology|June 27, 2020
Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA TrialJeanne E Poole, Tristram D Bahnson, Kristi H Monahan, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Circulation|May 9, 2007
Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Ronald S Freudenberger, Anne S Hellkamp, Jonathan L Halperin, et al.
Environmental and Molecular Mutagenesis|November 14, 2021
Utility of a next-generation framework for assessment of genomic damage: A case study using the pharmaceutical drug candidate etoposideJohn Nicolette, Mirjam Luijten, Jennifer C Sasaki, et al.
Eclinicalmedicine|February 4, 2025
Inter-pregnancy interval and uterine rupture during a trial of labour after one previous caesarean delivery and no previous vaginal births: a retrospective population-based cohort studyPejman Adily, Travis Bettison, Mark Lauer, et al.
AIDS Research and Human Retroviruses|April 18, 2002
Mother-to-child transmission in the United States of subtypes D and A/G human immunodeficiency virus type 1Paul Krogstad, Susan H Eshleman, Yongzhi Geng, et al.
Journal of the American College of Cardiology|April 15, 2014
Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)Daniel P Fishbein, Anne S Hellkamp, Daniel B Mark, et al.
Mutagenesis|October 24, 2024
Industrial Genotoxicology Group: 36th Annual Meeting ReportDarren Kidd, Ian Crooks, Angela Saccardo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2002
Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1Paul Krogstad, Sophia Lee, George Johnson, et al.
Regulatory Toxicology and Pharmacology : RTP|April 16, 2021
Use of less-than-lifetime (LTL) durational limits for nitrosamines: Case study of N-Nitrosodiethylamine (NDEA)Joel P Bercu, Melisa Masuda-Herrera, George Johnson, et al.
Heart Rhythm|June 23, 2015
SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac deathWan-Tai M Au-Yeung, Per G Reinhall, Jeanne E Poole, et al.
Journal of the American College of Cardiology|June 27, 2020
Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA TrialJeanne E Poole, Tristram D Bahnson, Kristi H Monahan, et al.
Pageof 10